Recent increase in non-tuberculous mycobacterial infection in patients with connective tissue diseases in Japan
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 26 (9) , 941-945
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Increasing patients with pulmonary Mycobacterium avium complex disease and associated underlying diseases in JapanJournal of Infection and Chemotherapy, 2015
- Increased risk of mycobacterial infections associated with anti-rheumatic medicationsThorax, 2015
- Prognostic Factors and Radiographic Outcomes of Nontuberculous Mycobacterial Lung Disease in Rheumatoid ArthritisThe Journal of Rheumatology, 2013
- Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in JapanModern Rheumatology, 2012
- Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin‐17A productionArthritis & Rheumatism, 2010
- Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2008
- Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritisModern Rheumatology, 2007
- Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanerceptThorax, 2007
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999Thorax, 2000